🔎 Trials Near Me

Home › Glioma › Ohio › Columbus

Pag-aaral pangklinika para sa Glioma sa Columbus, OH

Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Nagre-recruitPhase 1/2
  • Nationwide Children's Hospital, Columbus
12 Months – 21 Years · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Nagre-recruitPhase 2
  • Ohio State University, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nagre-recruitPhase 2
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2
  • Nationwide Children's Hospital, Columbus
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2
  • Nationwide Children's Hospital, Columbus
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2
  • The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Nagre-recruit
  • Ohio State University Medical Center, Columbus
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06910306

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Nagre-recruitPhase 1/2
  • Nationwide Children's Hospital, Columbus
Edad 4 hanggang 39 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
  • Nationwide Children's Hospital, Columbus
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Nagre-recruitPhase 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT06964737

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Nagre-recruitPhase 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Nagre-recruitMaagang Phase 1
  • Nationwide Children's Hospital, Columbus
Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Nagre-recruitPhase 1
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Lahat ng kasarian · Na-update May 13, 2025 · NCT04254419

Pag-aaral para sa Glioma sa ibang lungsod

Iba pang pag-aaral sa Columbus

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.